Statement of Organization, Functions, and Delegations of Authority
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Secretary of Health and Human Services delegates to the Food and Drug Administration (FDA) Commissioner the authorities vested in the Secretary of Health and Human Services (the Secretary) under section 3855 of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, as amended, to send annual letters to Congress regarding the progress of FDA in: evaluating the Over-the-Counter Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use with respect to children under the age of 6, and as appropriate, revising that monograph through the order process of section 505G(b) of the Federal Food, Drug, and Cosmetic Act to address such children. These authorities may be redelegated. Exercise of this authority shall be in accordance with established policies, procedures, guidelines, and regulations as prescribed by the Secretary.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 41 (Thursday, March 2, 2023)</title>
</head>
<body><pre>[Federal Register Volume 88, Number 41 (Thursday, March 2, 2023)]
[Notices]
[Page 13126]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-04009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Secretary of Health and Human Services delegates to the
Food and Drug Administration (FDA) Commissioner the authorities vested
in the Secretary of Health and Human Services (the Secretary) under
section 3855 of the Coronavirus Aid, Relief, and Economic Security
(CARES) Act, as amended, to send annual letters to Congress regarding
the progress of FDA in: evaluating the Over-the-Counter Monograph M012:
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products
for Over-the-Counter Human Use with respect to children under the age
of 6, and as appropriate, revising that monograph through the order
process of section 505G(b) of the Federal Food, Drug, and Cosmetic Act
to address such children. These authorities may be redelegated.
Exercise of this authority shall be in accordance with established
policies, procedures, guidelines, and regulations as prescribed by the
Secretary.
DATES: This authority delegation was approved by the Secretary on
February 22, 2023.
Dated: February 22, 2023.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2023-04009 Filed 3-1-23; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.